Comparison of the Semisolid Agar Antifungal Susceptibility Test with the NCCLS M38-P Broth Microdilution Test for Screening of Filamentous Fungi

Journal of Clinical Microbiology

Volumn 42, Issue 3, 2004, Pages 1224-1227

  Kuzucu, Cigdem ^a   Rapino, Barbara ^b   McDermott, Laura ^b   Hadley, Susan ^b,c  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BROTH MICRODILUTION METHOD; DIAGNOSTIC ACCURACY; FUNGUS; FUNGUS CULTURE; FUNGUS ISOLATION; FUSARIUM; MINIMUM INHIBITORY CONCENTRATION; MOULD; MUCOR; NONHUMAN; PENICILLIUM; PRIORITY JOURNAL; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; SEMISOLID AGAR ANTIFUNGAL SUSCEPTIBILITY TEST; TRICHOPHYTON; YEAST;

AGAR; ANTIFUNGAL AGENTS; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGY; SENSITIVITY AND SPECIFICITY;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; FUNGI; FUSARIUM; MUCOR; PENICILLIUM; PENICILLIUM SP.; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; TRICHOPHYTON;

EID: 1542409119     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.3.1224-1227.2004     Document Type: Article

References (11)

1. Espinel-Ingroff, A., M. Bartlett, R. Bowden, N. X. Chin, C. Cooper, Jr., A. Fothergill, M. R. McGinnis, P. Menezes, S. A. Messer, P. W. Nelson, F. C. Odds, L. Pasarell, J. Peter, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, G. S. Shankland, T. J. Walsh, and I. Weitzman. 1997. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J. Clin. Microbiol. 35:139-143.
2. Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. Dixon, A. Fothergill, V. Paetznick, J. Peter, and M. Rinaldi. 1995. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob. Agents Chemother. 39:314-319.
3. Espinel-Ingroff, A., and T. M. Kerkering. 1991. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. J. Clin. Microbiol. 29:393-394.
4. Gehrt, A., J. Peter, P. A. Pizzo, and T. J. Walsh. 1995. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J. Clin. Microbiol. 33:1302-1307.
5. Hadley, S., J. A. Martinez, L. McDermott, B. Rapino, and D. R. Snydman. 2002. Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients. J. Antimicrob. Chemother. 49:415-419.
6. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
7. McNeil, M. M., S. L. Nash, R. A. Hajjeh, M. A. Phelan, L. A. Conn, B. D. Plikaytis, and D. W. Warnock. 2001. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin. Infect. Dis. 33:641-647.
8. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium forming filamentous fungi; proposed standard M38-P. National Committee for Clinical Laboratory Standards. Wayne, Pa
9. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards. Wayne, Pa.
10. Provine, H., and S. Hadley. 2000. Preliminary evaluation of a semisolid agar antifungal susceptibility test for yeasts and molds. J. Clin. Microbiol. 38:537-541.
11. Rex, J. H., and M. A. Pfaller. 2002. Has antifungal susceptibility testing come of age? Clin. Infect. Dis. 35:982-989.